Pregnancy Outcome after In Utero Exposure to ValproateEvidence of Dose Relationship in Teratogenic Effect

被引:0
|
作者
Orna Diav-Citrin
Svetlana Shechtman
Benjamin Bar-Oz
Dana Cantrell
Judy Arnon
Asher Ornoy
机构
[1] The Hebrew University Hadassah Medical School,The Israeli Teratology Information Service, Israel Ministry of Health and Laboratory of Teratology, Department of Anatomy and Cell Biology
[2] Hadassah and Hebrew University Medical Center,The Department of Neonatology
[3] The Hebrew University and Hadassah Medical School,undefined
来源
CNS Drugs | 2008年 / 22卷
关键词
Valproate; Spina Bifida; Hypospadias; Major Malformation; Major Congenital Anomaly;
D O I
暂无
中图分类号
学科分类号
摘要
Background: Valproate is a first-line antiepileptic agent and is also used in the treatment of bipolar disorder and migraine. It is a known human teratogen. The objective of the study was to evaluate the teratogenic risk of valproate.
引用
收藏
页码:325 / 334
页数:9
相关论文
共 50 条
  • [41] Pregnancy Outcomes with Exposure to Mycophenolic Acid Products: Is There a Dose Relationship?
    Sifontis, N. M.
    Constantinescu, S.
    Coscia, L. A.
    McGrory, C. H.
    Axelrod, P.
    Moritz, M. J.
    Armenti, V. T.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2011, 11 : 206 - 206
  • [42] Pregnancy Outcome after First Trimester Exposure to Quinolones
    Watanabe, O.
    Nakajima, K.
    Ishii, M.
    Yakuwa, N.
    Murashima, A.
    BIRTH DEFECTS RESEARCH PART A-CLINICAL AND MOLECULAR TERATOLOGY, 2013, 97 (05) : 367 - 367
  • [43] PREGNANCY OUTCOME AFTER GESTATIONAL EXPOSURE TO AMIODARONE IN CANADA
    MAGEE, LA
    DOWNAR, E
    SERMER, M
    BOULTON, BC
    ALLEN, LC
    KOREN, G
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1995, 172 (04) : 1307 - 1311
  • [44] Pregnancy outcome after exposure to migalastat: A case study
    Haninger-Vacariu, Natalja
    El-Hadi, Sarah
    Pauler, Udo
    Foretnik, Marina
    Kain, Renate
    Schmidt, Alice
    Skuban, Nina
    Barth, Jay A.
    Sunder-Plassmann, Gere
    MOLECULAR GENETICS AND METABOLISM, 2018, 123 (02) : S57 - S58
  • [45] Long-Term Neurodevelopmental Outcome of Children after in Utero Exposure to Chemotherapy
    Korakiti, Anna-Maria
    Zografos, Eleni
    van Gerwen, Mathilde
    Amant, Frederic
    Dimopoulos, Meletios-Athanasios
    Zagouri, Flora
    CANCERS, 2020, 12 (12) : 1 - 16
  • [46] Neonatal outcome after exposure to indomethacin in utero: A retrospective case cohort study
    Abbasi, S
    Gerdes, JS
    Sehdev, HM
    Samimi, SS
    Ludmir, J
    AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2003, 189 (03) : 782 - 785
  • [47] Is there a difference between various presentations of valproate for cognitive outcome after in utero exposure?
    Gelisse, Philippe
    Genton, Pierre
    Crespel, Arielle
    EPILEPSIA, 2016, 57 (03) : 523 - 524
  • [48] Neurological outcome in school-age children after in utero exposure to coumarins
    Wesseling, J
    Van Driel, D
    Smrkovsky, M
    Van der Veer, E
    Geven-Boere, LM
    Sauer, PJJ
    Touwen, BCL
    EARLY HUMAN DEVELOPMENT, 2001, 63 (02) : 83 - 95
  • [49] Effects of in utero and lactational exposure to triphenyltin chloride on pregnancy outcome and postnatal development in rat offspring
    Grote, K.
    Hobler, C.
    Andrade, A. J. M.
    Wichert Grande, S.
    Gericke, C. C.
    Appel, K. E.
    Chahoud, I
    NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 2007, 375 : 79 - 79
  • [50] Effects of in utero and lactational exposure to triphenyltin chloride on pregnancy outcome and postnatal development in rat offspring
    Grote, Konstanze
    Hobler, Carolin
    Andrade, Anderson J. M.
    Grande, Simone Wichert
    Gericke, Christine
    Talsness, Chris E.
    Appel, Klaus E.
    Chahoud, Ibrahim
    TOXICOLOGY, 2007, 238 (2-3) : 177 - 185